格列美脲
別名: Amaryl, Amarel, Amarylle, Euglim, Glimepil, Solosa, Roname
藥物類別: Sulfonylurea Antidiabetic Agent
請了解此藥物在貓身上屬於「試驗性」用藥。若發現任何不良反應（如低血糖引起的虛弱、發抖或癲癇），請立即聯繫獸醫師。
劑量必須由獸醫依你寵物的個別情況決定。切勿在沒有獸醫指導下給予人類藥物或其他寵物的處方藥。
用途
- Treatment of NIDDM
- Treatment of NIDDM
給藥方式
PO
可能的副作用
- Hypoglycemia
- Dizziness
- Asthenia
- Liver function impairment (rare)
- Allergic respiratory reactions (rare)
- Dermatologic reactions (rare)
- Hematologic reactions (rare)
注意事項與禁忌
- Hypersensitivity to glimepiride or other sulfonylureas
- Diabetic ketoacidosis (DKA)
- > **Warning:** Do not confuse glimepiride with other sulfonylureas such as glipizide or glyburide. - **Pregnancy:** FDA Category C. Animal studies show intrauterine deaths secondary to maternal hypoglycemia. Avoid use during pregnancy. - **Nursing:** Excreted in maternal milk; manufacturer recommends discontinuing in nursing mothers. - **Hepatic/Renal Impairment:** Use with caution as metabolism and excretion may be delayed, increasing the risk of hypoglycemia.
藥物相互作用
- Azole Antifungals (ketoconazole, itraconazole, fluconazole): May increase plasma levels of glimepiride
- Beta-Blockers: May potentiate hypoglycemic effect
- Chloramphenicol: May displace glimepiride from plasma proteins
- Corticosteroids: May reduce efficacy
- Thiazide Diuretics: May reduce hypoglycemic efficacy
- Isoniazid: May reduce hypoglycemic efficacy
- Niacin: May reduce hypoglycemic efficacy
- Phenothiazines: May reduce hypoglycemic efficacy
- Phenytoin: May reduce hypoglycemic efficacy
- Sulfonamides: May displace glimepiride from plasma proteins
- Sympathomimetic Agents: May reduce hypoglycemic efficacy
- Warfarin: May displace glimepiride from plasma proteins
常見問題
格列美脲用於寵物有什麼用途？
請了解此藥物在貓身上屬於「試驗性」用藥。若發現任何不良反應（如低血糖引起的虛弱、發抖或癲癇），請立即聯繫獸醫師。
格列美脲對我的寵物安全嗎？
劑量必須由獸醫依你寵物的個別情況決定。切勿在沒有獸醫指導下給予人類藥物或其他寵物的處方藥。
本文僅供一般健康教育，不能取代專業獸醫意見。如寵物身體不適，請諮詢獸醫。